Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

413 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Renal cell carcinoma treated with stereotactic radiotherapy with histological change confirmed on autopsy: a case report.
Onishi H, Kawasaki T, Zakoji H, Yoshida T, Komiyama T, Kuriyama K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga L, Marino K, Watanabe I, Oguri M, Araki T, Enomoto N, Takeda M, Katoh R. Onishi H, et al. Among authors: araya m. BMC Res Notes. 2014 Apr 26;7:270. doi: 10.1186/1756-0500-7-270. BMC Res Notes. 2014. PMID: 24767701 Free PMC article.
Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy.
Satoh Y, Nambu A, Onishi H, Sawada E, Tominaga L, Kuriyama K, Komiyama T, Marino K, Aoki S, Araya M, Saito R, Maehata Y, Oguri M, Araki T. Satoh Y, et al. Among authors: araya m. Eur J Radiol. 2012 Nov;81(11):3530-4. doi: 10.1016/j.ejrad.2011.11.047. Epub 2011 Dec 16. Eur J Radiol. 2012. PMID: 22178287 Clinical Trial.
Intrafractional setup errors in patients undergoing non-invasive fixation using an immobilization system during hypofractionated stereotactic radiotherapy for lung tumors.
Watanabe M, Onishi H, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Tominaga R, Oguri J, Sano N, Araki T. Watanabe M, et al. Among authors: araya m. J Radiat Res. 2013 Jul 1;54(4):762-8. doi: 10.1093/jrr/rrt001. Epub 2013 Feb 14. J Radiat Res. 2013. PMID: 23412467 Free PMC article.
Renal Cancer is Not Radioresistant: Slowly but Continuing Shrinkage of the Tumor After Stereotactic Body Radiation Therapy.
Funayama S, Onishi H, Kuriyama K, Komiyama T, Marino K, Araya M, Saito R, Aoki S, Maehata Y, Nonaka H, Tominaga L, Muramatsu J, Nakagomi H, Kamiyama M, Takeda M. Funayama S, et al. Among authors: araya m. Technol Cancer Res Treat. 2019 Jan 1;18:1533033818822329. doi: 10.1177/1533033818822329. Technol Cancer Res Treat. 2019. PMID: 30803362 Free PMC article.
Stereotactic body radiotherapy in patients with lung tumors composed of mainly ground-glass opacity.
Onishi H, Shioyama Y, Matsumoto Y, Shibamoto Y, Miyakawa A, Suzuki G, Nishimura Y, Sasaki R, Miyawaki D, Kuriyama K, Komiyama T, Marino K, Aoki S, Saito R, Araya M, Maehata Y, Nonaka H, Tominaga L, Saito M, Sano N, Yamada S. Onishi H, et al. Among authors: araya m. J Radiat Res. 2020 May 22;61(3):426-430. doi: 10.1093/jrr/rraa015. J Radiat Res. 2020. PMID: 32219316 Free PMC article.
413 results